Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term statin pretreatment for endothelial ischemia-reperfusion injury
NL-OMON33420Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rosuvastatin and atorvastatin in ischemia-reperfusion injury (IRI) and myocardial infarction (MI), sponsored by Radboud University Medical Center. Started Oct 2009; status: active, not recruiting.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
ischemia-reperfusion injury (IRI)myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON33420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33420.